Oncolab, Inc. - CANNOT EXHIBIT, OWES AACC17
Oncolab is seeking international distribution for its pioneering in-vitro cancer diagnostic test, the AMAS test. This quantitative antibody/antigen assay, with FDA permission to market and CLIA certification, is currently run at our US lab in Boston, MA; using serum samples, it offers greater than 90% sensitivity and specificity across all major cancer types. We are developing a version for 2015 deployment at POC facilities worldwide, at $100-200 retail. For further info -www.oncolabinc.com.
Included in Export Interest Directory? Yes
Products to be exported: AMAS cancer immunoassay